Independent Research, SPACs, SPAC Track

SPAC Track

Independent Research, SPACs

Equity Capital Markets

<ul><li>HealthCor Catalio Acquisition Corp.​ (HCAQ) sets 12/21 as the date for its shareholder meeting to vote on its merger with Hyperfine &amp; Liminal Sciences</li><li>Yucaipa Acquisition Corp (YAC) sets 12/13 as the date for its shareholder meeting to vote on its merger with SIGNA Sports</li><li>East Stone Acquisition Corporation (ESSC) <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1760683/000121390021062185/ea151419-8k_eaststone.htm" target="_blank" rel="noopener">shareholders approved</a> the deadline extension to 2/24/22 with 10.5M shares redeemed</li></ul>

HealthCor Catalio Acquisition Corp.​ (HCAQ) sets 12/21 as the date for its shareholder meeting to vote on its merger with Hyperfine &amp; Liminal SciencesYucaipa Acquisition Corp (YAC) sets 12/13 as the date for its shareholder meeting to vote on its merger with SIGNA SportsEast Stone Acquisition Corporation (ESSC) shareholders approved the deadline extension to 2/24/22 with 10.5M shares redeemed

United States

Hyperfine, Inc. operates as a medical equipment company. The Company designs and manufactures portable magnetic resonance imaging devices. Hyperfine serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hyperfine (HYPR US)

The Ackman Variant

HealthCor Catalio Acquisition Corp. (HCAQ) sets 12/21 as the date for its shareholder meeting to vote on its merger with Hyperfine & Liminal...

SPAC Track

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

The Ackman Variant

HealthCor Catalio Acquisition Corp.​ (HCAQ) sets 12/21 as the date for its shareholder meeting to vote on its merger with Hyperfine & Liminal...

SPAC Track

HealthCor Catalio Acquisition Corp. (HCAQ) sets 12/21 as the date for its shareholder meeting to vote on its merger with Hyperfine & Liminal...